Jump to Content

FDA requests more data on “Low T”

/ Dangerous Drugs /

FDA requests more data on "Low T"NEW YORK – The U.S. Food and Drug Administration is asking companies for more safety data on testosterone drugs after a patient broke out in hives during a mid-stage trial.

According to Reuters, the FDA is becoming more cautious with testosterone drugs since it discovered a large percentage of patients didn’t get their hormone levels tested before or during treatment.

Reuters reports the FDA requested data on 350 patients exposed to QuickShot Testosterone, a drug introduced by Antares Pharma Inc. The pharmaceutical company reports it may have to submit more data based on its ongoing late-stage trial.

Antares is currently in the testing phase of QuickShot Testosterone and the government’s request for more data could delay its regulatory and marketing applications.

Leave a Reply

Your email address will not be published. Required fields are marked *

Client Thanks

I would like to thank your firm for representing our family on behalf of my late husband. This whole process was, at times, difficult for us and sometimes painful. But, we were always in good hands as Brian and Maria are two of the hardest working and sincerest people I have ever had the pleasure of meeting. They did a tremendous job.

Read more →

Recent Tweets

Social Accounts


Office Locations

350 Main Street
2500 Main Place Twr
Buffalo, NY 14202
(716) 888-8888
(800) 888-8888
Map & Directions

Grider Street Office
451 Grider Street
Buffalo, NY 14215
(716) 888-8888
(800) 888-8888
Map & Directions

Garden City
600 Old Country Rd
Suite 412
Garden City, NY 11530
(800) 888-8888
Map & Directions

420 Lexington Ave
21st Floor
New York, NY 10170
(800) 888-8888
Maps & Directions

532 Broad Hollow Road
Melville, NY
(800) 888-8888
Map & Directions

16 W. Main Street
Powers Building, Suite 600
Rochester, NY 14614
(585) 888-8888
(800) 888-8888
Map & Directions


Free Case Evaluation

Fields marked with a * are required
↑ Top